Advanced Glaucoma Technologies

Advanced Glaucoma Technologies (AGT) is a medical device company specializing in the development of surgical solutions for glaucoma management. The company is best known for its AGT Glaucoma Drainage Device, a micro-invasive surgical implant designed to lower intraocular pressure by facilitating aqueous humor outflow. Founded by ophthalmologist Dr. Richard Hill, the company aimed to provide safer and more effective alternatives to traditional glaucoma surgeries. In 2017, AGT was acquired by Iantech, which was later acquired by Alcon in 2019. The company's technology has since been integrated into Alcon's extensive ophthalmology portfolio. The device represents a significant advancement in the field of micro-invasive glaucoma surgery (MIGS).